Abstract
A number of clinical studies have demonstrated correlation between elevated levels of factor IX and the risk of coronary heart disease. Studies by different groups have shown that blocking procoagulant activity of factor IXa could reduce the risk of thrombosis. We propose to study the regulation of factor IXa by phosphatidylserine (PS) which further could open up possibilities to design drugs that might inhibit the up regulation of the procoagulant protein factor IXa. The activated form of factor IX, IXa, forms the Xase complex together with factor VIIIa and Ca2+ on an activated platelet membrane surface. We hypothesize that PS regulates factor IXa by binding to specific sites on factor IXa and thereby enhancing its catalytic activity. We used a soluble form of phosphatidylserine, 1,2-dicaproyl-sn-glycero-3-phospho-L-serine (C6PS) as a tool in order to address the role of PS in regulating factor IXa. Intrinsic fluorescence measurements demonstrate that C6PS binds tightly (Kd ~1.3 μM) to and induces changes in conformation of factor IXa. We also monitored the amidolytic activity of 300 nM factor IXa in the presence of C6PS using synthetic substrate Leu-PHG-Arg-pNA. There is a reduction in the amidolytic activity of factor IXa with increasing addition of C6PS and the hyperbolic fit gives an apparent Kd of 130 μM. Recent results show that calcium is required for both amidolytic and proteolytic activity of factor IXa in the presence of C6PS. Our data shows that amidolytic activity of factor IXa in the presence of 600 mM C6PS is saturated at a concentration of calcium near 3 mM. We have also demonstrated that both C6PS and calcium enhance proteolytic activation of factor X by factor IXa. The data shows that as the concentration of Ca2+ increases, the proteolytic activation of factor X by factor IXa increases as well. Enhancement of factor X activation appears to saturate at a calcium concentration of 3 mM. Based on these results, we conclude, 1) C6PS induces a conformational change in factor IXa, 2) C6PS regulates the amidolytic and proteolytic activity of factor IXa, 3) Ca2+ is needed for PS mediated regulation of factor IXa.
Supported by US Public Health Service Grants GM32707 (BRL) and HL6350 (DMM)
Author notes
Corresponding author
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal